A novel aminosterol reverses diabetes and fatty liver disease in obese mice

Journal of Hepatology

Volumn 41, Issue 3, 2004, Pages 391-398

  Takahashi, Nobuhiko ^a   Qi, Yong ^a   Patel, Hiral R ^a   Ahima, Rexford S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ACOx, acylCoA oxidase; Adiponectin; Aminosterol; CPT, carnitine palmitoyltransferase; Diabetes; FAS, fatty acid synthase; GPAT, glycerol 3 phosphate acyltransferase; Non alcoholic fatty liver; Obesity; SREBP, sterol regulatory element binding protein

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; AMINOSTEROL; GLUCOSE; INSULIN; LIPID; LIVER ENZYME; MSI 1436; STEROL DERIVATIVE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; ENERGY EXPENDITURE; FAT CONTENT; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE METABOLISM; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LIVER; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION;

ANIMALS; BASE SEQUENCE; BODY WEIGHT; CHOLESTANOLS; DIABETES COMPLICATIONS; FATTY LIVER; FEMALE; GENE EXPRESSION; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; ORGAN SIZE; RNA, MESSENGER;

EID: 4344566976     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.05.006     Document Type: Article

References (22)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 346:2002;1221-1231
2. Hookman P., Barkin J.S. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach. Am J Gastroenterol. 98:2002;2093-2097
3. Reddy J.K. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 281:2001;G1333-G1339
4. Lin H.Z., Yang S.Q., Chuckaree C., Kuhajda F., Ronnet G., Diehl A.M. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med. 6:2000;998-1003
5. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Zoli M., Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet. 358:2001;893-894
6. Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., Oliver D., Bacon B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology. 38:2003;1008-1017
7. Ahima R.S., Patel H.R., Takahashi N., Qi Y., Hileman S.M., Zasloff M.A. Appetite suppression and weight reduction by a centrally active aminosterol. Diabetes. 51:2002;2099-3104
8. Rao M.N., Shinnar A.E., Noecker L.A., Chao T.L., Feibush B., Snyder B., et al. Aminosterols from the dogfish shark Squalus acanthias. J Nat Prod. 63:2000;631-635
9. Zasloff M., Williams J.I., Chen Q., Anderson M., Maeder T., Holroyd K., et al. A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties. Int J Obes Relat Metab Disord. 25:2001;689-697
10. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science. 297:2002;240-243
11. Yahagi N., Shimano H., Hasty A.H., Matsuzaka T., Ide T., Yoshikawa T., et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem. 277:2002;19353-19357
12. Takahashi N., Patel H.R., Qi Y., Dushay J., Ahima R.S. Divergent effects of leptin in mice susceptible or resistant to obesity. Horm Metab Res. 34:2002;691-697
13. Nagy T.R., Clair A.L. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res. 8:2000;392-398
14. Jin W., Millar J.S., Broedl U., Glick J.M., Rader D.J. Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J Clin Invest. 111:2003;357-362
15. Bartels E.D., Lauritsen M., Nielsen L.B. Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes. 51:2002;1233-1239
16. Liang C.P., Tall A.R. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem. 276:2001;49066-49076
17. Koteish A., Diehl A.M. Animal models of steatosis. Semin Liver Dis. 21:2001;89-104
18. Kirsch R., Clarkson V., Shephard E.G., Marais D.A., Jaffer M.A., Woodburne V.E., et al. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol. 18:2003;1272-1282
19. Shimomura I., Bashmakov Y., Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem. 274:1999;30028-30032
20. Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 13:2002;84-89
21. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 8:2002;731-737
22. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 112:2003;91-100